Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including respiratory, oncology, and pain management. It also offers its products in solid, semi-solid, liquid, and injectable final dosage forms. The company operates in the United Kingdom, rest of Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, the United Kingdom.

Hikma Pharmaceuticals PLC

Engineer Said Samih Taleb Darwazah

Executive Chairman

Mr. Riad Ali Mishlawi

CEO & Director

Mr. Mazen Samih Taleb Darwazah

Executive Vice Chairman & President of MENA

Mr. Khalid Waleed Hosny Al Nabilsi CPA

Chief Financial Officer

Patricia  Bousfield

Chief Information Officer

Mr. Guy  Featherstone

Associate Director of Investor Relations

Mr. Samuel  Park

General Counsel

Mr. Bassam Wael Rushdi Kanaan CFA, CPA

Executive Vice President of Corporate Development and M&A

Mr. Hussein Omar Arkhagha

Chief People Officer

Ms. Susan  Ringdal

Executive Vice President of Strategic Planning & Global Affairs

HIK's next earnings is on April 25, 2025 (After Market Close)

HIK's latest dividend is 0.32 GBP on August 15, 2024

Hikma Pharmaceuticals PLC (HIK) Stock Analysis, Discussion Forum and Financial Metrics - LSE Exchange

Hikma Pharmaceuticals PLC (HIK) Earnings Report Date and History | LSE

HIK's next earnings is on April 25, 2025 (After Market Close)

When is the earnings report for HIK?

HIK Earnings History

HIK's latest dividend is 0.32 GBP on August 15, 2024

HIK Stock Discussion Forum and Message Board

News for LSE: HIK